Sign in

You're signed outSign in or to get full access.

Robin H. Karlsen

Independent Director at Aimei Health Technology
Board

About Robin H. Karlsen

Independent director at AFJK since November 2023; Norwegian citizen, resident in Singapore. Background in cross-border real estate investment and development with graduate training in real estate finance (Master’s, University of Hong Kong, June 2016) and a bachelor’s in Urban Studies (UCL Bartlett, May 2015) . Listed age: 32 in the latest proxy with directors table . Serves on key board committees and is deemed independent under Nasdaq standards .

Past Roles

OrganizationRoleTenureCommittees/Impact
PIK InternationalInvestment DirectorDec 2018 – Feb 2022Oversaw identification and investment in real estate assets in Asia
CFLD International Pte. Ltd.Business Development ManagerJun 2016 – Nov 2018Biz dev across Asia, Middle East and Africa for industrial city development

External Roles

OrganizationRoleTenureNotes
ROHKA Pte. Ltd.PresidentFeb 2022 – PresentStrategic consultancy for real estate investments
AYA Land Development Ltd.PartnerJun 2022 – PresentStrategic consultancy for real estate investments

Board Governance

  • Independence: Classified as an independent director under Nasdaq listing standards; independent directors meet in regular executive sessions .
  • Committees and roles:
    • Audit Committee – Member (committee chaired by Lin Bao; all members independent; committee financial expert: Lin Bao) .
    • Compensation Committee – Member (committee chaired by Dr. Julianne Huh) .
    • Nominating Committee – Chair (all members independent) .
  • Audit Committee remit includes related-party transaction pre-approval and auditor independence oversight .

Fixed Compensation

ComponentAmount/TermsNotes
Annual retainer (pre-business combination)$0“No compensation or fees of any kind… will be paid to our … directors… prior to or in connection with the consummation of our initial business combination,” other than reimbursement of out-of-pocket expenses .
Meeting/committee fees (pre-business combination)$0Same as above .
Expense reimbursementPermittedOut-of-pocket expenses reimbursable; audit committee/board to review/approve .

The company’s articles also allow directors to be remunerated and reimbursed expenses generally, and fees may be determined by the board/ordinary resolution; this is a general enablement provision, not a specific program disclosure .

Performance Compensation

ElementStatusDetails
Equity planTo be adoptedPubco expects to adopt an Equity Incentive Plan subject to shareholder approval in connection with business combination; schedule/amounts not yet determined .
Post-closing director/executive compensationNot yet determinedFollowing the closing, compensation to be developed by Pubco’s compensation committee; specifics TBD .

No performance metrics (e.g., TSR, EBITDA, ESG) tied to director compensation were disclosed in the current filings .

Other Directorships & Interlocks

CategoryDisclosure
Current public company boardsNone identified in the AFJK proxy biography for Karlsen .
Family relationshipsNone among directors/officers (per proxy) .
Potential conflicts (business combination)“To our knowledge, there is no actual or potential material conflict of interest” in connection with the business combination for officers/directors, per proxy section addressing the transaction .

Expertise & Qualifications

  • Education: Master’s in Real Estate Finance and Investment (University of Hong Kong, June 2016); Bachelor’s in Urban Studies (UCL Bartlett, May 2015) .
  • Domain: Cross-border real estate investment; strategic consultancy; Asia/Middle East/Africa business development .
  • Board qualifications highlighted by company: Extensive cross-border business experience and network of contacts .

Equity Ownership

HolderShares Beneficially Owned% OutstandingBasis/Date
Robin Hoksnes Karlsen20,000* (less than 1%)Table based on 6,121,733 ordinary shares outstanding “as of the date” of the Oct 10, 2025 proxy/prospectus .

Historical reference: Prior proxy (Jan 21, 2025) shows Karlsen 20,000 shares, “*%” on a 9,026,000 share base at that time .

Governance Assessment

  • Strengths for board effectiveness:

    • Independence with leadership responsibility as Chair of the Nominating Committee; contributes to board refreshment and governance processes .
    • Service on Audit and Compensation Committees provides cross-committee visibility; audit remit explicitly covers related-party transactions and auditor independence .
    • Independent director executive sessions established, supporting oversight quality .
  • Alignment and incentives:

    • Personal shareholding exists but is small (20,000 shares; <1%), offering limited direct economic alignment; pre-combination, directors received no cash/equity fees (SPAC-standard), reducing pay-related conflicts but also limiting at-risk alignment .
    • Post-closing equity incentives are contemplated but not yet determined; monitoring the eventual director equity mix and any ownership guidelines will be important for alignment assessment .
  • Conflicts and related-party oversight:

    • Audit Committee pre-approves related-party transactions; proxy states no material conflicts in connection with the business combination to the company’s knowledge .
  • RED FLAGS to monitor:

    • Ownership concentration and changes post-business combination; current individual director holdings are de minimis .
    • Absence of disclosed attendance metrics; ensure future proxies include attendance and engagement data (not disclosed in retrieved sections) .
    • Future design of director compensation (cash vs equity, performance linkages) remains TBD; watch for excessive guaranteed cash or lack of holding requirements .

Note: Attempts to retrieve Form 4 insider trading data via the insider-trades skill for “Robin Karlsen” on AFJK encountered an authorization error; no additional Form 4 insight could be added beyond proxy ownership tables in this report.